Lower diagnostic costs needed for HBV peripartum antiviral prophylaxis to be effective
The addition of peripartum antiviral prophylaxis to reduce neonatal hepatitis B virus infection could have “substantial extra health benefits,” although decreased diagnostic costs are needed to make this strategy cost-effective.“WHO’s Global Health Sector Strategy on Viral Hepatitis set a target for elimination of mother-to-child transmission of HBV, with the aim to reach
Source: healio.com
